(Q39696941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author

Satyendra C. Tripathi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jatinder Kaur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Ajay Matta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Xin Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Bin Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Shyam Singh Chauhan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Alok Thakar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nootan Kumar Shukla

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ritu Duggal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ajoy Roy Choudhary

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Siddhartha DattaGupta

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Mehar Chand Sharma

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ranju Ralhan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K W Michael Siu

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

14 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

14-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002576%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.145

14 January 2020

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Nomenclature and classification of potentially malignant disorders of the oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Management of salivary hypofunction during and after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Traditional Chinese medicine and oral diseases: today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

New advances in molecular approaches to head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC-1: a Rho GTPase-activating protein and tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC1: a significant GAP in the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

GAP control: regulating the regulators of small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

21 January 2018

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

Characterization of DLC1-SAM equilibrium unfolding at the amino acid residue level

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC1 negatively regulates angiogenesis in a paracrine fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Survival model predictive accuracy and ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Oral premalignant lesions: from a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Oral premalignant lesions: from the pathological viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Analysis of DLC-1 expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

Profiling early head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

Oral dysplasia: biomarkers, treatment, and follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

Genetics/epigenetics of oral premalignancy: current status and future research

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

DLC1 and liver cancer: the Akt connection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021

The DLC-1 -29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.145

7 January 2021